Rapport Therapeutics, Inc.
RAPP
$27.70
$0.582.14%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 59.99% | -22.52% | 47.68% | 107.00% | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 736.44% | 645.38% | -98.14% | -80.00% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -97.60% | -96.75% | 5,124.76% | 122.91% | -- |
| Total Current Assets | 59.74% | -20.67% | 46.42% | 105.34% | -- |
|
|
|||||
| Total Current Assets | 59.74% | -20.67% | 46.42% | 105.34% | -- |
| Net Property, Plant & Equipment | 171.05% | 171.20% | 98.14% | 24.28% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 465.08% | 447.09% | -89.82% | -70.96% | -- |
| Total Assets | 61.66% | -17.51% | 46.42% | 102.63% | -- |
|
|
|||||
| Total Accounts Payable | 144.52% | 69.39% | 47.72% | -21.90% | -- |
| Total Accrued Expenses | 70.08% | 25.87% | -19.55% | 7.90% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 244.72% | 150.21% | 46.94% | 10.00% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 101.66% | 46.74% | -5.08% | -0.41% | -- |
|
|
|||||
| Total Current Liabilities | 101.66% | 46.74% | -5.08% | -0.41% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 908.59% | 804.57% | 426.50% | -49.93% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 195.22% | 138.63% | 45.01% | -34.35% | -- |
|
|
|||||
| Common Stock & APIC | 67.17% | 3.50% | 1,414.77% | 2,070.17% | -- |
| Retained Earnings | -94.16% | -102.42% | -117.02% | -172.34% | -- |
| Treasury Stock & Other | -63.75% | 58.47% | 40.63% | -13,150.00% | -- |
| Total Common Equity | 58.34% | -21.78% | 821.21% | 1,291.49% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 58.34% | -21.78% | 821.21% | 1,291.49% | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 58.34% | -21.78% | 46.50% | 116.70% | -- |
|
|
|||||